03-Dec-2013 - Unilife has agreed to supply customised drug delivery devices to Novartis in the fourth major deal inked in the last few months.
02-Dec-2013 - Apotek Produktion & Laboratorier AB (APL) says manufacturing knowledge and drug delivery tech knowhow gained by its compounding business is a boon for its CMO unit.
26-Nov-2013 - Unilife has signed a $40m long-term supply agreement with Hikma and says it is committed to becoming the world’s largest and most successful injectable drug delivery systems supplier.
26-Nov-2013 - Novo Nordisk has teamed up with Roche to launch a prefilled cartridge for insulin pump users and says the system offers advantages over injections.
25-Nov-2013 - Particle Sciences has been tasked with creating a nasal formulation of the steroid hormone progesterone that can be used to treat patients who have suffered traumatic brain injury.
21-Nov-2013 - Aptar Pharma has launched a new auto-injector technology as part of a strategic effort to build its presence in the biopharmaceutical sector.
20-Nov-2013 - Eli Lilly is investing over $700m (€518m) at a number of its insulin producing sites globally saying it is a response to the “growing diabetes epidemic.”
13-Nov-2013 - Drug delivery experts say fixed dose combination (FDC) products for non-oral forms can benefit both the manufacturer and the patient.
12-Nov-2013 - There are multiple ways to make amorphous dispersions in order to enhance bioavailability but spray dry dispersion (SDD) is often the most applicable, Bend Research says.
12-Nov-2013 - Understanding how a drug will interact with food is vital even if predicting it accurately during development can be a challenge according to speakers at AAPS yesterday.
05-Nov-2013 - A new tableting excipient eliminates the need for wet granulation and saves up to 60% on overall manufacturing costs according to developer Dow.
31-Oct-2013 - The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the firms say, as the first drug delivery tech is transferred.
28-Oct-2013 - Dow says the acquisition of partner Bend Research is “good news” and will strengthen its developments in solving solubility and bioavailability issues in drug formulation.
23-Oct-2013 - Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.
23-Oct-2013 - Indian manufacturing heavyweight Mylan Laboratories is looking to build off its major acquisition of Agila with a number of smaller acquisitions, while Natco is about to receive a cash infusion for manufacturing expansions.
22-Oct-2013 - Linking peptide and small molecule drugs to albumin will improve pharmacokinetics, says Almac as it partners its manufacturing capabilities with Novozymes’ half-life extension platform.
17-Oct-2013 - US and French regulators have given Oxford BioMedica the go ahead to restart studies of three eye drugs it is developing with Sanofi after an impurity found in trial materials was identified as a harmless culture media derivative.
17-Oct-2013 - Cirrus Pharmaceuticals has received a grant to investigate the effect of excipient concentration and API molecule size on metered dose inhaler (MDI) formulations.
15-Oct-2013 - AstraZeneca has become the latest company to invest in antibody-drug conjugate (ADC) technology with the acquisition of Spirogen for $200m (€148m).
15-Oct-2013 - Colorcon has called on Evonik Industries to help it sell a co-developed, delayed release pill coating technology.
14-Oct-2013 - Roche will build an antibody-drug conjugate production facility to support production of its approved drug Kadcyla and others in its development pipeline.
10-Oct-2013 - Catalent has continued its softgel expansion in emerging markets with the acquisition of Relthy Laboratórios in Brazil.
09-Oct-2013 - An intravaginal ring filled with an anti-retroviral drug being developed by Northwestern University could be used to deliver drugs for a number of indications, says the Professor behind the research.
08-Oct-2013 - Enteris has secured its first partnership to develop metabolic peptides for Nordic Bioscience using an oral delivery platform it says offers unparalleled bioavailability.
07-Oct-2013 - Aesica has started expanding capacity at its pre-filled syringe plant in the UK after predicting a surge in demand.
Dispatches from AAPS
The US FDA is working with GEA to validate continuous manufacturing as the pharma industry enters “the start...
The US FDA and European Medicines Agency (EMA) is now offering additional joint guidance on the concept...
Novartis has confirmed it is closing a UK facility as part of a global R&D review but...
In one of the largest healthcare fraud settlements in US history, Johnson & Johnson has pleaded guilty to...
The acquisition of Bend Research by Capsugel may be “a marriage made in heaven” for customers, the...